UCL Discovery
UCL home » Library Services » Electronic resources » UCL Discovery

Re: [177Lu]Lu-PSMA-617 Versus Cabazitaxel in Patients with Metastatic Castration-resistant Prostate Cancer (TheraP): A Randomised, Open-label, Phase 2 Trial.

Adeleke, S; Haroon, A; Kasivisvanathan, V; (2021) Re: [177Lu]Lu-PSMA-617 Versus Cabazitaxel in Patients with Metastatic Castration-resistant Prostate Cancer (TheraP): A Randomised, Open-label, Phase 2 Trial. European Urology 10.1016/j.eururo.2021.04.005. (In press). Green open access

[thumbnail of Kasivisvanathan_TheraP letter to editor-4 accepted.pdf]
Preview
 Text
Kasivisvanathan_TheraP letter to editor-4 accepted.pdf - Accepted Version
Download (90kB) | Preview
Type: Article
Title: Re: [177Lu]Lu-PSMA-617 Versus Cabazitaxel in Patients with Metastatic Castration-resistant Prostate Cancer (TheraP): A Randomised, Open-label, Phase 2 Trial.
Location: Switzerland
Open access status: An open access version is available from UCL Discovery
DOI: 10.1016/j.eururo.2021.04.005
Publisher version: https://doi.org/10.1016/j.eururo.2021.04.005
Language: English
Additional information: This version is the author accepted manuscript. For information on re-use, please refer to the publisher’s terms and conditions.
UCL classification: UCL
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Surgery and Interventional Sci
UCL > Provost and Vice Provost Offices > School of Life and Medical Sciences > Faculty of Medical Sciences > Div of Surgery and Interventional Sci > Department of Targeted Intervention
URI: https://discovery.ucl.ac.uk/id/eprint/10127798
Downloads since deposit
Loading...
310Downloads
Download activity - last month
Loading...
Download activity - last 12 months
Loading...
Downloads by country - last 12 months
1.China
33
2.United States
26
3.United Kingdom
6
4.Australia
5
5.Germany
5
6.Canada
3
7.Iran, Islamic Republic of
2
8.Russian Federation
2
9.Korea, Republic of
2
10.India
2
102550all

Archive Staff Only

View Item View Item